{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:36:16Z","timestamp":1793500576578,"version":"4.5.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.jiac.2022.07.015","type":"journal-article","created":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T04:36:59Z","timestamp":1659415019000},"page":"1562-1566","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Development of intravascular large B-cell lymphoma during prophylactic antibiotic treatment for anti-interferon-gamma autoantibody syndrome: A case report"],"prefix":"10.1016","volume":"28","author":[{"given":"Tomomi","family":"Tanigaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4026-7506","authenticated-orcid":false,"given":"Yoshifumi","family":"Kimizuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8926-7320","authenticated-orcid":false,"given":"Yohei","family":"Maki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8124-9785","authenticated-orcid":false,"given":"Chikako","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Yoshimatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiraku","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakika","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0654-7176","authenticated-orcid":false,"given":"Masashi","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Serizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunya","family":"Igarashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhei","family":"Kurata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3189-1702","authenticated-orcid":false,"given":"Jun","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Fujikura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8534-8852","authenticated-orcid":false,"given":"Kimiya","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Kawana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2022.07.015_bib1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/cid\/ciz786","article-title":"Natural history and evolution of anti-interferon-\u03b3 autoantibody-associated immunodeficiency syndrome in Thailand and the United States","volume":"71","author":"Hong","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2022.07.015_bib2","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s12879-020-4949-4","article-title":"Triple infection with Cryptococcus, varicella-zoster virus, and Mycobacterium abscessus in a patient with anti-interferon-gamma autoantibodies: a case report","volume":"20","author":"Rujirachun","year":"2020","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jiac.2022.07.015_bib3","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1182\/blood-2018-04-842559","article-title":"Immunodeficiency-associated lymphoproliferative disorders: time for reappraisal?","volume":"132","author":"Natkunam","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jiac.2022.07.015_bib4","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1349-7006.2004.tb03248.x","article-title":"The critical role of type-1 innate and acquired immunity in tumor immunotherapy","volume":"95","author":"Ikeda","year":"2004","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jiac.2022.07.015_bib5","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1182\/blood-2006-01-021253","article-title":"Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5","volume":"109","author":"Murase","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jiac.2022.07.015_bib6","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2141.2004.05177.x","article-title":"Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the \u2018cutaneous variant\u2019","volume":"127","author":"Ferreri","year":"2004","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.jiac.2022.07.015_bib7","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1600-0609.2007.01008.x","article-title":"A clinicopathological study of 13 cases of intravascular lymphoma: experience in a single institution over a 9-yr period","volume":"80","author":"Matsue","year":"2008","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jiac.2022.07.015_bib8","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1093\/cid\/cix996","article-title":"Clinical significance of interferon-\u03b3 neutralizing autoantibodies against disseminated nontuberculous mycobacterial disease","volume":"66","author":"Aoki","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2022.07.015_bib9","doi-asserted-by":"crossref","first-page":"e3927","DOI":"10.1097\/MD.0000000000003927","article-title":"Clinical manifestations, course, and outcome of patients with neutralizing anti-interferon-\u03b3 autoantibodies and disseminated nontuberculous mycobacterial infections","volume":"95","author":"Chi","year":"2016","journal-title":"Med (Baltim)"},{"key":"10.1016\/j.jiac.2022.07.015_bib10","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1097\/PAS.0000000000001731","article-title":"Lymphadenopathy associated with neutralizing anti-interferon-gamma autoantibodies could have monoclonal T-cell proliferation indistinguishable from malignant lymphoma and treatable by antibiotics: a clinicopathologic study","volume":"45","author":"Yuan","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jiac.2022.07.015_bib11","doi-asserted-by":"crossref","first-page":"17937","DOI":"10.18632\/oncotarget.24788","article-title":"Phytochemicals as modulators of M1-M2 macrophages in inflammation","volume":"9","author":"Saqib","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.jiac.2022.07.015_bib12","doi-asserted-by":"crossref","first-page":"ofab181","DOI":"10.1093\/ofid\/ofab181","article-title":"R-CHOP chemotherapy for disseminated Mycobacterium avium complex disease due to anti-interferon-gamma autoantibodies: a case report","volume":"8","author":"Uno","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jiac.2022.07.015_bib13","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S1470-2045(20)30059-0","article-title":"Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial","volume":"21","author":"Shimada","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jiac.2022.07.015_bib14","series-title":"NCCN clinical guidelines in oncology (NCCN guidelines), B-cell lymphomas","year":"2021"},{"key":"10.1016\/j.jiac.2022.07.015_bib15","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1182\/blood-2011-12-395707","article-title":"Anti-CD20 (rituximab) therapy for anti-IFN-\u03b3 autoantibody-associated nontuberculous mycobacterial infection","volume":"119","author":"Browne","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jiac.2022.07.015_bib16","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1093\/cid\/cit809","article-title":"Rituximab as successful adjunct treatment in a patient with disseminated nontuberculous mycobacterial infection due to acquired anti-interferon-\u03b3 autoantibody","volume":"58","author":"Czaja","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2022.07.015_bib17","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1093\/cid\/ciaa1086","article-title":"Daratumumab (anti-CD38) for treatment of disseminated nontuberculous mycobacteria in a patient with anti-interferon-\u03b3 autoantibodies","volume":"72","author":"Ochoa","year":"2021","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X22002112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X22002112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:05:33Z","timestamp":1761159933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X22002112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":17,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S1341321X22002112"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2022.07.015","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of intravascular large B-cell lymphoma during prophylactic antibiotic treatment for anti-interferon-gamma autoantibody syndrome: A case report","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2022.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}